DOI QR코드

DOI QR Code

Chemotherapy of Mammary Comedocarcinoma with Doxorubicin in a Dog

  • Kim, Yeonsoo (College of Veterinary Medicine, Chungnam National University) ;
  • Seo, Kyoungwon (College of Veterinary Medicine, Seoul National University) ;
  • Song, Kunho (College of Veterinary Medicine, Chungnam National University)
  • Received : 2021.07.26
  • Accepted : 2021.11.19
  • Published : 2021.12.31

Abstract

An 11-year-old, intact female, Miniature Poodle presented with an abdominal mass. The abdominal mass was located around the right fifth mammary gland. The surgically removed mammary mass was subjected to histopathological examination. Based on the microscopic interpretation, a final diagnosis of an intermediate grade infiltrative mammary comedocarcinoma was established. Computed tomography for metastasis evaluation after surgical resection of the tumor showed enlarged right medial iliac and right inguinal lymph nodes, and a micronodule in the accessory lung lobe, suggesting metastasis of the mammary gland tumor. Doxorubicin, a chemotherapeutic drug, was administered six times at three week intervals. However, despite chemotherapy, the masses around the fourth and fifth mammary gland on the right side enlarged in size, and the treatment was discontinued at the request of the owner. The anticancer response to mammary comedocarcinoma is poor and the patient is in hospice management. This is the first attempt to treat a case of canine mammary comedocarcinoma in South Korea.

Keywords

References

  1. Borrego JF. Urogenital and mammary gland tumors. In: Ettinger SJ, Feldman EC, Cote E, editors. Textbook of veterinary internal medicine: diseases of the dog and the cat. 8th ed. St. Louis: Elsevier. 2017: 2119-2126.
  2. Goldschmidt M, Pena L, Rasotto R, Zappulli V. Classification and grading of canine mammary tumors. Vet Pathol 2011; 48: 117-131. https://doi.org/10.1177/0300985810393258
  3. Merlo DF, Rossi L, Pellegrino C, Ceppi M, Cardellino U, Capurro C, et al. Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. J Vet Intern Med 2008; 22: 976-984. https://doi.org/10.1111/j.1939-1676.2008.0133.x
  4. Rasotto R, Berlato D, Goldschmidt MH, Zappulli V. Prognostic significance of canine mammary tumor histologic subtypes: an observational cohort study of 229 cases. Vet Pathol 2017; 54: 571-578. https://doi.org/10.1177/0300985817698208
  5. Simon D, Schoenrock D, Baumgartner W, Nolte I. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. J Vet Intern Med 2006; 20: 1184-1190. https://doi.org/10.1892/0891-6640(2006)20[1184:PATIMM]2.0.CO;2
  6. Sleeckx N, de Rooster H, Veldhuis Kroeze EJ, Van Ginneken C, Van Brantegem L. Canine mammary tumours, an overview. Reprod Domest Anim 2011; 46: 1112-1131. https://doi.org/10.1111/j.1439-0531.2011.01816.x
  7. Sorenmo KU, Worley DR, Goldschmidt MH. Tumors of.the.mammary.gland. In: Vail DM, Thamm DH, Liptak JM, editors. Withrow & MacEwen's small animal clinical oncology. 6th ed. St. Louis: Elsevier. 2020: 604-625.
  8. Valdivia G, Alonso-Diez A, Perez-Alenza D, Pena L. From conventional to precision therapy in canine mammary cancer: a comprehensive review. Front Vet Sci 2021; 8: 623800. https://doi.org/10.3389/fvets.2021.623800